US Patent 9518049 Salt forms of (S)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
Patent 9518049 was granted and assigned to Genzyme on December, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 14, 2014
Date of Patent
December 13, 2016
Patent Applicant
Patent Application Number
14776432
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9518049 Salt forms of (S)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
